UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Gene-Based Vaccines and Immunotherapeutics

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14567-14571

2004

Volltextzugriff (PDF)

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines

International journal of nanomedicine, 2018-01, Vol.13, p.337-349

2018

Volltextzugriff (PDF)

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

Journal of immunotherapy, 2000-09, Vol.23 (5), p.570-580

2000

Volltextzugriff (PDF)

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Cancer Immunology, Immunotherapy, 2000, Vol.48 (10), p.588-594

2000

Volltextzugriff (PDF)

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Gene therapy, 2000-09, Vol.7 (17), p.1447-1457

2000

Volltextzugriff (PDF)

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Cancer Immunology, Immunotherapy, 2001-10, Vol.50 (8), p.397-407

2001

Volltextzugriff (PDF)

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9536-9546

2005

Volltextzugriff (PDF)

An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting andin vivocross-reactive T cell responses

Vaccine, 2007-10, Vol.25 (42), p.7339

2007

Volltextzugriff (PDF)

Enveloped Virus Is the Major Virus Form Produced during Productive Infection with the Modified Vaccinia Virus Ankara Strain

Virology (New York, N.Y.), 2000-07, Vol.273 (1), p.9-15

2000

Volltextzugriff (PDF)

Molecular cloning of a protective antigen of schistosomes

Nature (London), 1987-03, Vol.326 (6109), p.149-153

1987

Volltextzugriff (PDF)

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Human gene therapy, 2000-07, Vol.11 (10), p.1417-1428

2000

Volltextzugriff (PDF)

A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis

The Journal of immunology (1950), 1987-05, Vol.138 (10), p.3448

1987

Volltextzugriff (PDF)

Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni

Parasite immunology, 1991-09, Vol.13 (5), p.473-490

1991

Volltextzugriff (PDF)

Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen

Journal of immunotherapy with emphasis on tumor immunology, 1993-08, Vol.14 (2), p.136

1993

Volltextzugriff (PDF)

The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni

The EMBO journal, 1988-02, Vol.7 (2), p.465-472

1988

Volltextzugriff (PDF)

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2

Breast cancer research : BCR, 2001-05, Vol.3 (Suppl 1), p.A10-A10, Article A10

2001

Volltextzugriff (PDF)

Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase

Molecular and biochemical parasitology, 1990-06, Vol.41 (1), p.35-44

1990

Volltextzugriff (PDF)

High level of expression of a protective antigen of schistosomes in Saccharomyces cerevisiae

Yeast (Chichester, England), 1989-11, Vol.5 (6), p.497-507

1989

Volltextzugriff (PDF)

Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen

The Journal of immunology (1950), 1989-02, Vol.142 (4), p.1342

1989

Volltextzugriff (PDF)

Variations in protein expression related to human eosinophil heterogeneity

The Journal of immunology (1950), 1989-06, Vol.142 (12), p.4416

1989

Volltextzugriff (PDF)

Quantitative and qualitative analysis of the Fc receptor for IgE (FcεRII) on human eosinophils

European journal of immunology, 1988-02, Vol.18 (2), p.237-241

1988

Volltextzugriff (PDF)

Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides

The Journal of immunology (1950), 1988-09, Vol.141 (5), p.1687

1988

Volltextzugriff (PDF)

Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer

Cellular and molecular biology (Noisy-le-Grand, France), 1994, Vol.40 Suppl 1, p.49

1994

Volltextzugriff (PDF)

Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection

Infection and Immunity, 1987-05, Vol.55 (5), p.1163-1169

1987

Volltextzugriff (PDF)

Protective antigens in experimental schistosomiasis

Acta tropica. Supplementum, 1987-06, Vol.12, p.63

1987

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Animals
(18)
Biological And Medical Sciences
(13)
Humans
(12)
Immunology
(12)
Mice
(11)
Fundamental And Applied Biological Sciences. Psychology
(9)
Schistosoma Mansoni
(7)
Antigens, Helminth - Immunology
(6)
Immunotherapy
(6)
Schistosoma Mansoni - Immunology
(6)
Antigens
(5)
Base Sequence
(5)
Biochemistry & Molecular Biology
(5)
Cloning, Molecular
(5)
Immunization
(5)
Male
(5)
Oncology
(5)
Rats
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gene-Based Vaccines and Immunotherapeutics

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting andin vivocross-reactive T cell responses

Enveloped Virus Is the Major Virus Form Produced during Productive Infection with the Modified Vaccinia Virus Ankara Strain

Molecular cloning of a protective antigen of schistosomes

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis

Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni

Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen

The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2

Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase

High level of expression of a protective antigen of schistosomes in Saccharomyces cerevisiae

Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen

Variations in protein expression related to human eosinophil heterogeneity

Quantitative and qualitative analysis of the Fc receptor for IgE (FcεRII) on human eosinophils

Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides

Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer

Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection

Protective antigens in experimental schistosomiasis

Suchergebnisse filtern